Iridex Corp (IRIX) - News Archive

In a landscape marked by rapid technological advancements and fierce competition, Iridex Corporation (NASDAQ: IRIX), a prominent player in the medical device industry, has found itself at a crossroads. Founded with the...

ArticleIn a bold move that underscores both the potential and precarious state of Iridex Corporation (NASDAQ: IRIX), the Mountain View-based company recently closed a strategic investment deal worth $10 million, backed...

Iridex Faces Stock Market Turbulence Amid Groundbreaking Innovation in Glaucoma TreatmentBy CSI Market MOUNTAIN VIEW, Calif. — In the face of considerable stock price volatility, Iridex Corporation (NASDAQ: IRIX), a rec...

The management of glaucoma, a leading cause of irreversible blindness worldwide, has reached a new horizon with the announcement from Iridex Corporation regarding a groundbreaking five-year study on MicroPulse Transscle...

Iridex Corporation, a global leader in providing laser-based medical systems and devices for the treatment of glaucoma and retinal diseases, has recently announced the execution of definitive agreements for a private pl...

Iridex Corporation, situated in Mountain View, California, and Imperial College Healthcare NHS Trust in London, have announced their first patient enrolment in a collaborative medical research study. The study is set to...

Celebrating 35 Years of Laser Innovation: Iridex Introduces Next-Generation Lasers for Retina Disorders and Glaucoma Treatment in the US MarketMOUNTAIN VIEW, Calif., Jan. 11, 2024 - Iridex Corporation, a renowned global...